Results 1-14 of 14 (Search time: 0.004 seconds).

Issue DateTitleAuthor(s)
11-May-2018Both the intratumoral immune and microbial microenvironment are linked to recurrence in human colon cancer: Results from a prospective, multicenter nodal ultrastaging trialNoguti J.; Chan A.; Bandera B.; Brislawn C.; Mlađan Protić ; Sim M.; Jansson J.; Bilchik A.; Lee D.
21-Oct-2019Building a collaboration to improve surgical research through EORTC/ESSO 1409-CLIMB study: A prospective liver metastasis database with an integrated quality assurance programCaballero C.; Burock S.; Carrion-Alvarez L.; Nilsson H.; Ruers T.; Senellart P.; Rivoire M.; Stattner S.; Primavesi F.; Troisi R.; Gruenberger T.; Heil J.; Schnitzbauer A.; Rahbari N.; Swijnenburg R.; Malik H.; Mlađan Protić ; Kataoka K.; Mauer M.; Ducreux M.; Poston G.; Evrard S.
31-Jan-2013Clinical decision support and individualized prediction of survival in colon cancer: Bayesian belief network modelStojadinović, Alexander; Bilchik A.; Smith D.; Eberhardt J.; Ward E.; Nissan A.; Johnson E.; Mlađan Protić ; Peoples G.; Avital I.; Steele S.
41-Jan-2014Dysfunctional Ectopic Thyroid Gland: A Case ReportEdita Stokić ; Vladimir Kljajić ; Stevan Idjuški; Damir Benc ; Đorđe Popović ; Mlađan Protić ; Veljko Crnobrnja
51-Jan-2011An international perspective on interest in a general surgery career among final-year medical studentsAre C.; Stoddard H.; Prete F.; Tianqiang S.; Northam L.; Chan S.; Lee J.; Jani P.; Mlađan Protić ; Venkateshwarulu S.; Sarela A.; Thompson J.
61-May-2018The Negative Impact of Body Mass Index on the Tumor Microenvironment in Colon Cancer: Results of a Prospective TrialFlaherty D.; Jalas J.; Sim M.; Stojadinović, Alexander; Mlađan Protić ; Lee D.; Bilchik A.
71-Feb-2016Postoperative complications and overall survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinomaPugalenthi A.; Mlađan Protić ; Gonen M.; Kingham T.; Angelica M.; Dematteo R.; Fong Y.; Jarnagin W.; Allen P.
81-Jan-2015Prognostic Effect of Ultra-Staging Node-Negative Colon Cancer Without Adjuvant Chemotherapy: A Prospective National Cancer Institute-Sponsored Clinical TrialMlađan Protić ; Stojadinović, Alexander; Nissan A.; Wainberg Z.; Steele S.; Chen D.; Avital I.; Bilchik A.
91-Feb-2017Prospective randomized controlled trial comparing standard analgesia with combined intra-operative cystic plate and port-site local anesthesia for post-operative pain management in elective laparoscopic cholecystectomyMlađan Protić ; Radovan Veljković ; Bilchik A.; Popović, Ana; Milana Kresoja ; Nissan A.; Avital I.; Stojadinović, Alexander
1030-Aug-2013Serum-based DNA methylation biomarkers in colorectal cancer: Potential for screening and early detectionSummers T.; Langan R.; Nissan A.; Brücher B.; Bilchik A.; Mlađan Protić ; Daumer M.; Avital I.; Stojadinović, Alexander
111-Jul-2017Sex-Specific Differences in Colon Cancer when Quality Measures Are Adhered to: Results from International, Prospective, Multicenter Clinical TrialsGaitonde S.; Nissan A.; Mlađan Protić ; Stojadinović, Alexander; Wainberg Z.; Chen D.; Bilchik A.
121-May-2014Time-dependent estimates of recurrence and survival in colon cancer: Clinical decision support system tool development for adjuvant therapy and oncological outcome assessmentSteele S.; Bilchik A.; Johnson E.; Nissan A.; Peoples G.; Berhardt J.; Kalina P.; Petersen B.; Brücher B.; Mlađan Protić ; Avital I.; Stojadinović, Alexander
131-Dec-2012Time-dependent trends in lymph node yield and impact on adjuvant therapy decisions in colon cancer surgery: An international multi-institutional studyStojadinović, Alexander; Nissan A.; Wainberg Z.; Shen P.; McCarter M.; Mlađan Protić ; Howard R.; Steele S.; Peoples G.; Bilchik A.
141-Jan-2015Value of Primary Tumor Gene Signatures in Colon Cancer When National Quality Standards are Adhered to: Preliminary Results of an International Prospective Multicenter TrialBilchik A.; Wainberg Z.; Nissan A.; Slamon D.; Mlađan Protić ; Avital I.; Chen H.; Chen D.; Sim M.; Elashoff D.; Stojadinović, Alexander